Infectious Disease Advisor news story
Virologically suppressed adults with HIV-1 who switch to doravirine-based antiretroviral therapy achieve long-term viral control and stable quality of life (QOL), highlighting the high level of treatment satisfaction and clinical durability associated with these regimens.
Researchers performed a real-world cohort study using a 2-step analytical approach across 15 sites in France to evaluate treatment durability and QOL among 143 virologically suppressed patients (HIV-1 RNA <50 copies/mL) with HIV switching to doravirine-based ART.
Read the full news story here.
/Infectious Disease Advisor requires free registration if more than 5 articles are viewed per month/
Source : Infectious Disease Advisor
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.